Global Artificial Lung Market Size, Insights, Forecasts to 2035
Introduction:
The Global Artificial Lung Market is experiencing significant growth, driven by the increasing prevalence of respiratory diseases, rising incidence of cardiopulmonary disorders, growing demand for extracorporeal life support (ECLS), and continuous advancements in artificial lung technologies. Artificial lungs are widely used in critical care settings to provide temporary respiratory support for patients with severe lung failure, particularly during complex cardiac surgeries and acute respiratory distress syndrome (ARDS). Increasing healthcare investments, expanding ICU infrastructure, and technological innovations in oxygenation devices are expected to drive market growth during the forecast period.
Get Free Sample Of This Premium Report:
https://www.decisionsadvisors.com/request-sample/DAR4483
Global Rotary Actuators Market Insights
- Based on Decision Advisors findings, the Global Artificial Lung Market was estimated at USD 2.45 Billion in 2024 and is expected to reach USD 6.67 Billion by 2035.
- From 2025 to 2035, the global market is expected to grow at a CAGR of 9.53%.
- Within the Product Type category, Extracorporeal Membrane Oxygenation (ECMO) Systems accounted for the largest market share.
- Over the forecast period, Portable Artificial Lung Systems are anticipated to witness the fastest growth due to increasing demand for advanced respiratory support, technological innovations, and expanding applications in critical care.
Other Key Findings
- North America accounted for the largest share of the Global Artificial Lung Market.
- North America is expected to grow the fastest during the forecast period.
- Europe represented the third-largest regional market.
- Rising investments in critical care infrastructure, increasing cases of chronic respiratory diseases, and growing adoption of ECMO technology are expected to drive market growth.
Report Summary
|
Report Scope |
Details |
|
Base Year for Study |
2024 |
|
Study Period |
2021–2035 |
|
Historical Period |
2021–2024 |
|
Forecast Period |
2025–2035 |
|
Market Size In 2025 |
USD 2.45 Billion |
|
Market Size In 2035 |
USD 6.67 Billion |
|
Largest segment |
Extracorporeal Membrane Oxygenation (ECMO) Systems |
|
Units |
Revenue in USD Billion |
|
CAGR |
9.53% (2025–2035) |
|
Segmentation Covered |
|
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
|
By Distribution Channel |
|
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
|
Companies |
Abbott Laboratories, Abiomed (Johnson & Johnson MedTech), ALung Technologies, Inc., Braile Biomédica, Getinge AB, Hemovent GmbH, LivaNova PLC, MC3 Cardiopulmonary, Medtronic plc, MicroPort Scientific Corporation, Nipro Corporation, Novalung GmbH (a Xenios company), Xenios AG (Fresenius Medical Care), Others |
Want detailed insights, forecasts, and competitive analysis?
Check out the full report now:
https://www.decisionsadvisors.com/reports/artificial-lung-marke
Connect with us
- USA - +1 303 800 4326
- APAC - +1 303 800 4326
- sales@sphericalinsights.com